Serum Monocyte Chemoattractant Protein-1 in Pancreatic Cancer

Table 1

Clinicopathological characteristics of PDA patients and MCP-1 levels.

	PDA 𝑛=62	%	MCP-1 (pg/mL) mean ± SEM	𝑃 value	Survival at 12 months	𝑃 value
Average age (yrs)	64.7
<60 (mean 52.9)	20		211.1 ± 68.37	0.12	83%	0.9
>60 (mean 70.2)	42		232.91 ± 51.69		74%
M	28	45	209.1 ± 50.5	0.9	85%	0.5
F	34	55	239.7 ± 62.9		67.9%
BMI
Normal weight (<25)	20	32	174.3 ± 30.7		77.7%
Overweight (25–29.9)	28	45	227.8 ± 55.3	0.09	75.7%	0.08
Obese (>30)	14	23	277.5 ± 141		71.3%
AJCC stage
I	5	8	69.12 ± 22.04		80%
II	46	74	228.43 ± 35.5	0.62	75%	0.4
III-IV	11	18	104.52 ± 15.6		62%
Grade
G1	8	13	280.15 ± 119.6		83%
G2	37	60	186.99 ±102.63	0.34	80%	0.5
G3-G4	17	27	302.63 ± 38.82		65%
Lymph nodes
N0	7	11	106.08 ± 30.37		83%
N1-N2	16	26	155.04 ± 26.77		80%
N3-N5	17	27	321.82 ± 85.19	0.07	63%	0.06
>N6	22	36	241.16 ± 91.066		50%